Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Organ Assist is a Dutch medical technology company focused on machine perfusion systems used to preserve, transport, and assess donor organs for transplantation. Originating from research linked to University Medical Center Groningen, the company developed oxygenated ex vivo perfusion devices intended to improve donor organ quality, extend preservation time, and increase utilization of transplantable organs. Its historical product portfolio included ECOPS, Kidney Assist, Liver Assist, and Lung Assist, with particular strength in abdominal organ perfusion. Organ Assist was acquired by XVIVO Perfusion in October 2020 and its technologies were subsequently integrated into XVIVO's broader organ preservation offering. The business is healthcare-related but is not a therapeutics developer; it operates in transplant medtech rather than biotech or pharma.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Organ Assist.